top of page
Medvin icon
Medvin Clinical Research

Call Toll Free:
 1 (855) MEDVIN-1

  • Instagram
  • Facebook
  • LinkedIn
gout.png

Gout Trials

The study utilizes an already FDA approved drug for the treatment of Gout that helps lower the Uric  Acid levels in patients. The patients DO NOT need to be on a Gout medication. Gout is a type of inflammatory arthritis caused by the accumulation of urate crystals in the joints, resulting in severe pain, swelling, and inflammation. This study aims to assess the potential of new therapies in managing gout symptoms and improving patient outcomes. The sponsor will provide Methotrexate medication to participants during the study.

Trial Details

participating criteria.png

Participation Criteria

  • Must be at least 18 years of age.

  • Presence or history of Gouty arthritis.

  • Must not have Chronic Kidney disease.

  • Must have Hyperuricemia during the Screening Period, defined as sUA ≥ 7 mg/dL.

locations.png

Participating Locations

  • Covina

  • Whittier

  • Riverside

  • Tujunga

  • Temecula

  • Menifee

compensation.png

  • Earn up to $ 4,800 total

  • $100 per visit for a total of 48 visits

Compensation

medications.png

  • FDA approved drug (No Placebo involved) all subject will receive active medication.

Medications

durations.png

  • 16-month study (Double-blind period 23 weeks, followed by Open-label extension week 24 - week 44).

Durations

bottom of page